We are approximately 21,000 people around the globe focused on developing advanced therapies that address some of the world’s most complex and serious diseases. We have a lot in common with the people we serve, and we come together every day to discover, create and deliver new ways for people just like us to enjoy good health. The company's drug portfolio includes Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis; Norvir, a treatment for HIV; Depakote, an anticonvulsant drug; and Synthroid, a synthetic thyroid hormone. The Global Security Department consist of International Security, Business Risk Intelligence, Global Command Center, Executive Protection and Travel Safety, Investigations, Regulatory Compliance, and Security Systems.Specialties: Project management, site assessments, physical security implementation, enterprise syestem integration and international travel.